BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 19127138)

  • 21. Emerging drugs for gastroesophageal reflux disease.
    Boeckxstaens GE
    Expert Opin Emerg Drugs; 2009 Sep; 14(3):481-91. PubMed ID: 19650746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in proton pump inhibitors and management of acid-peptic disorders.
    Jain KS; Shah AK; Bariwal J; Shelke SM; Kale AP; Jagtap JR; Bhosale AV
    Bioorg Med Chem; 2007 Feb; 15(3):1181-205. PubMed ID: 17150362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gradual cessation of proton pump inhibitor (PPI) treatment may prevent rebound acid secretion, measured by the alkaline tide method, in dyspepsia and reflux patients.
    Niv Y
    Med Hypotheses; 2011 Sep; 77(3):451-2. PubMed ID: 21723045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical trial: long-term use of proton pump inhibitors in primary care patients - a cross sectional analysis of 901 patients.
    Reimer C; Bytzer P
    Aliment Pharmacol Ther; 2009 Oct; 30(7):725-32. PubMed ID: 19604180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review of proton pump inhibitors for the initial treatment of heartburn: is there a dose ceiling effect?
    Kushner PR; Peura DA
    Adv Ther; 2011 May; 28(5):367-88. PubMed ID: 21484335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough.
    Mainie I; Tutuian R; Castell DO
    J Clin Gastroenterol; 2008 Jul; 42(6):676-9. PubMed ID: 18496394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Medical treatment efficient in chronic reflux. Also surgery has a given place in long-term therapy--for certain patients].
    Lundell L
    Lakartidningen; 2009 Feb 18-24; 106(8):502-5. PubMed ID: 19350782
    [No Abstract]   [Full Text] [Related]  

  • 28. New pharmacological agents for the treatment of gastroesophageal reflux disease.
    Vakil N
    Rev Gastroenterol Disord; 2008; 8(2):117-22. PubMed ID: 18641594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nocturnal gastroesophageal reflux disease: issues, implications, and management strategies.
    Johnson DA; Katz PO
    Rev Gastroenterol Disord; 2008; 8(2):98-108. PubMed ID: 18641592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of heartburn not responding to proton pump inhibitors.
    Fass R; Sifrim D
    Gut; 2009 Feb; 58(2):295-309. PubMed ID: 19136523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term acid inhibition: benefits and harms.
    Tepeš B
    Dig Dis; 2011; 29(5):476-81. PubMed ID: 22095013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proton pump inhibitor utilization patterns in infants.
    Barron JJ; Tan H; Spalding J; Bakst AW; Singer J
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):421-7. PubMed ID: 18030207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of use of proton pump inhibitors in Greece.
    Ntaios G; Chatzinikolaou A; Kaiafa G; Savopoulos C; Hatzitolios A; Karamitsos D
    Eur J Intern Med; 2009 Mar; 20(2):171-3. PubMed ID: 19327607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastric acid suppressants--too much of a good thing?
    Logan IC; Sumukadas D; Witham MD
    Age Ageing; 2010 Jul; 39(4):410-1. PubMed ID: 20507846
    [No Abstract]   [Full Text] [Related]  

  • 35. Unexpected consequences of proton pump inhibitor use.
    Altman KW; Radosevich JA
    Otolaryngol Head Neck Surg; 2009 Nov; 141(5):564-6. PubMed ID: 19861191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical therapy for gastroesophageal reflux disease in 2007.
    Katz PO
    Rev Gastroenterol Disord; 2007; 7(4):193-203. PubMed ID: 18192955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton pump inhibitors: bacterial pneumonia.
    Prescrire Int; 2012 Sep; 21(130):210-2. PubMed ID: 23016253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infants and proton pump inhibitors: tribulations, no trials.
    Orenstein SR; Hassall E
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):395-8. PubMed ID: 18030202
    [No Abstract]   [Full Text] [Related]  

  • 39. The use of acid-decreasing medication in veteran patients with gastro-oesophageal reflux disorder with and without Barrett's oesophagus.
    El-Serag HB; Wieman M; Richardson P
    Aliment Pharmacol Ther; 2008 Jun; 27(12):1293-9. PubMed ID: 18363892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proton pump inhibitors: the good, the bad, and the unwanted.
    Chubineh S; Birk J
    South Med J; 2012 Nov; 105(11):613-8. PubMed ID: 23128806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.